Cargando…

High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma

Shugoshin2 (SGO2) may participate in the occurrence and development of tumors by regulating abnormal cell cycle division, but its prognostic value in hepatocellular carcinoma (HCC) remains unclear. In this study, we accessed The Cancer Genome Atlas (TCGA) database to get the clinical data and gene e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Min, Li, Shaohua, Mei, Jie, Lin, Wenping, Zou, Jingwen, Wei, Wei, Guo, Rongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226836/ https://www.ncbi.nlm.nih.gov/pubmed/34200261 http://dx.doi.org/10.3390/genes12060876

Ejemplares similares

Sgo1 is a potential therapeutic target for hepatocellular carcinoma
por: Wang, Lyu-Han, et al.
Publicado: (2015)

Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation
por: Guan, Renguo, et al.
Publicado: (2022)

Surgical strategies for hepatocellular carcinoma located in the left lateral lobe: A propensity score‐matched and prognostic nomogram study
por: Zou, Jingwen, et al.
Publicado: (2021)

Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy
por: Deng, Min, et al.
Publicado: (2022)

Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma
por: Guan, Renguo, et al.
Publicado: (2022)

Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway
por: Mei, Jie, et al.
Publicado: (2022)

Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis
por: Zou, Jingwen, et al.
Publicado: (2021)

Sgo stabilizes glue and microtubules
por: Tuma, Rabiya
Publicado: (2004)

Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy
por: Deng, Min, et al.
Publicado: (2023)

What clinicopathological factors affect the recurrence of hepatocellular carcinoma after surgery?
por: Deng, Min, et al.
Publicado: (2022)

SET binding to Sgo1 inhibits Sgo1–cohesin interactions and promotes chromosome segregation
por: Qu, Qianhui, et al.
Publicado: (2019)

Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma
por: Li, Shaohua, et al.
Publicado: (2022)

The Significance of Notch1 Compared with Notch3 in High Metastasis and Poor Overall Survival in Hepatocellular Carcinoma
por: Zhou, Liang, et al.
Publicado: (2013)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Deng, Min, et al.
Publicado: (2023)

Decreased expression of COLEC10 predicts poor overall survival in patients with hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2018)

Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival
por: Yu, SiZhe, et al.
Publicado: (2020)

A preliminary study on drug switching strategy for second-line therapy after combination treatment of tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
por: Guan, Renguo, et al.
Publicado: (2022)

Bub1 targeting to centromeres is sufficient for Sgo1 recruitment in the absence of kinetochores
por: Williams, Samantha J., et al.
Publicado: (2016)

Polymorphism in asparagine synthetase is associated with overall survival of hepatocellular carcinoma patients
por: Li, Wei, et al.
Publicado: (2017)

Low APOA-1 Expression in Hepatocellular Carcinoma Patients Is Associated With DNA Methylation and Poor Overall Survival
por: Guo, Yingyun, et al.
Publicado: (2021)

Mechanistic basis for Sgo1-mediated centromere localization and function of the CPC
por: Abad, Maria Alba, et al.
Publicado: (2022)

Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma
por: Sun, Hao, et al.
Publicado: (2023)

The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma
por: Deng, Min, et al.
Publicado: (2022)

High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation
por: Wu, Zuotao, et al.
Publicado: (2023)

Sgo1 as a “guardian spirit” for preventing colon tumorigenesis
por: Ricke, Robin M., et al.
Publicado: (2012)

Does COVID-19 compromise SGO member well-being?
por: Carr, Caitlin, et al.
Publicado: (2021)

Squid Game Optimizer (SGO): a novel metaheuristic algorithm
por: Azizi, Mahdi, et al.
Publicado: (2023)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)

Sarcopenia and visceral adiposity predict poor overall survival in hepatocellular carcinoma patients after curative hepatic resection
por: Jang, Hee Yoon, et al.
Publicado: (2021)

Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2021)

A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients
por: Jia, Jie, et al.
Publicado: (2022)

Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study
por: Deng, Min, et al.
Publicado: (2023)

Haplo-insufficiency of both BubR1 and SGO1 accelerates cellular senescence
por: Park, Sung-Hyun, et al.
Publicado: (2016)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

Higher TOX Genes Expression Is Associated With Poor Overall Survival for Patients With Acute Myeloid Leukemia
por: Liang, Chaofeng, et al.
Publicado: (2021)

Artificial intelligence method to predict overall survival of hepatocellular carcinoma
por: Simsek, Cem, et al.
Publicado: (2021)

Overexpression of miR-664 is associated with poor overall survival and accelerates cell proliferation, migration and invasion in hepatocellular carcinoma
por: Wang, Xianming, et al.
Publicado: (2019)

A novel cuproptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma
por: Yang, Fan, et al.
Publicado: (2022)

‘SGoFicance Trace’: Assessing Significance in High Dimensional Testing Problems
por: de Uña-Alvarez, Jacobo, et al.
Publicado: (2010)

Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma
por: Ling, Yi-hong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0qk8c3nbl5j8sgf6i6ioqikv0o